REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
01/31/2026
Back to search
Official data from USPTO
EPIPEN EPIPEN JR (EPINEPHRINE INJECTION) AUTO-INJECTORS 0.3/0.15 MG
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
28
Latest update
02/01/2026
Trademark type
Combined
Nice classes
10
Filing date
04/19/2016
Registration date
01/31/2017
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
07/22/2022
Last transaction
02/01/2026
Responsible office
United States Patent and Trademark Office
Status code
702
Official register
Principal Register
First use anywhere
06/30/2015
First use in commerce
06/30/2015
Drawing code
3
Owner type
03
Owner location
Canonsburg, PA
Examiner
PINO, BRIAN
Law office
M50
Current location
POST REGISTRATION
Mark description
The mark consists of the stylized term "EPIPEN" in a yellow rectangle outlined in green next to the terms "EPIPEN JR" in a green rectangle outlined in yellow; both centered above the stylized terms "(EPINEPHRINE INJECTION) AUTO-INJECTORS 0.3/0.15mg" in a green rectangle line outlined in yellow; all wording is in black.
Holders and representatives
Holders
Mylan Inc.
Representatives
Mylan Inc.
Technical classification
Nice Classes
Class 10
Vienna Codes
No Vienna codes available.
Goods and services
Class 10
holders and cases for storing or carrying epinephrine auto-injectors
Publications
History of USPTO decisions and trademark events.
28 publications found
NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
07/22/2022
NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - MAILED
07/22/2022
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
07/22/2022
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
07/22/2022
E815
TEAS SECTION 8 & 15 RECEIVED
02/10/2022
E815
TEAS SECTION 8 & 15 RECEIVED
01/31/2022
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
01/31/2022
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
05/08/2018
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
05/08/2018
R.PR
REGISTERED-PRINCIPAL REGISTER
01/31/2017
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
11/15/2016
PUBO
PUBLISHED FOR OPPOSITION
11/15/2016
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
10/26/2016
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
10/07/2016
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
10/03/2016
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
09/30/2016
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
09/30/2016
ALIE
ASSIGNED TO LIE
09/29/2016
ALIE
ASSIGNED TO LIE
09/22/2016
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
09/13/2016
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
08/09/2016
GNRT
NON-FINAL ACTION E-MAILED
08/09/2016
CNRT
NON-FINAL ACTION WRITTEN
08/09/2016
DOCK
ASSIGNED TO EXAMINER
08/03/2016
MDSM
NOTICE OF DESIGN SEARCH CODE E-MAILED
04/26/2016
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
04/25/2016
NWAP
NEW APPLICATION ENTERED
04/22/2016
Continuous trademark protection
Get notified about every new filing that threatens EPIPEN EPIPEN JR (EPINEPHRINE INJECTION) AUTO-INJECTORS 0.3/0.15 MG or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.